SCHEMBL437859

SCHEMBL437859

CC(=O)N(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207868 1.00
Benzene SCHEMBL27854435 0.89 FFAR3 (0.38)
Methacrylic Acid SCHEMBL27535299 0.82 TDP1 (0.43)
SCHEMBL10417668 0.80 TSHR (0.41)
Acetone SCHEMBL28564801 0.78
SCHEMBL3439738 0.78
SCHEMBL25474034 0.75
Acetic Acid SCHEMBL28743669 0.75
SCHEMBL498258 0.75
SCHEMBL247472 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11505815-B2 Compositions and methods related to non-templated enzymatic nucleic acid synthesis NUCLERA NUCLEICS, LTD. (GB) 2022-11-22 US claimed
CN-111072566-B Preparation method and application of pyrazole derivative 宿迁市科莱博生物化学有限公司 2022-02-08 CN claimed
EP-3710461-A1 NUCLEOTIDE DERIVATIVES CONTAINING AMINE MASKED MOIETIES AND THEIR USE IN A TEMPLATED AND NON-TEMPLATED ENZYMATIC NUCLEIC ACID SYNTHESIS Nuclera Nucleics Ltd (GB) 2020-09-23 EP claimed
CN-111344296-A Nucleotide derivatives containing amine-masked moieties and their use in templated and non-templated enzymatic nucleic acid synthesis 核酸有限公司 2020-06-26 CN claimed
CN-111072566-A Preparation method and application of pyrazole derivative 宿迁市科莱博生物化学有限公司 2020-04-28 CN claimed
US-20190144905-A1 Novel Use Nuclera Nucleics Ltd. (GB) 2019-05-16 US claimed
EP-2885276-B1 PROCESS FOR THE PREPARATION OF PYRAZOLE CARBOXYLIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2016-06-01 EP claimed
US-9346763-B2 Process for the preparation of pyrazole carboxylic acid derivatives HOFFMAN-LA ROCHE INC. (US) 2016-05-24 US claimed
EP-2885276-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE CARBOXYLIC ACID DERIVATIVES F. Hoffmann-La Roche AG (CH) 2015-06-24 EP claimed
US-20150158818-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE CARBOXYLIC ACID DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2015-06-11 US claimed
CN-104540807-A Process for the preparation of pyrazole carboxylic acid derivatives HOFFMANN LA ROCHE 2015-04-22 CN claimed
WO-2014027009-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE CARBOXYLIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2014-02-20 WO claimed
JP-4805909-B2 2011-11-02 JP claimed
US-20250388585-A1 PRMT5 INHIBITORS AND USES THEREOF GILEAD SCIENCES INC (US) 2025-12-25 US disclosed
EP-4638436-A1 PRMT5 INHIBITORS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2025-10-29 EP disclosed
US-12448388-B2 PRMT5 inhibitors and uses thereof GILEAD SCIENCES, INC. (US) 2025-10-21 US disclosed
US-4202892-A FUNGICIDES, VIRICIDES, ANTIPROTOZOA AGENTS, PARKINSON'S DISEASE TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 1980-05-13 US disclosed
EP-0002065-A1 Methyladamantyl hydrazines, their pharmaceutically acceptable salts and pharmaceutical compositions containing them Teva Pharmaceutical Industries Limited (IL) 1979-05-30 EP disclosed
US-4045484-A FROM ACETHYDRAZIDE, FORMALDEHYDE AND HYDROGEN IN A PALLADIUM CATALYST UNIROYAL, INC. (US) 1977-08-30 US disclosed
US-3931268-A Methylhydrazinomethyl-substituted benzoic acid amides HOFFMANN-LA ROCHE INC. (US) 1976-01-06 US disclosed